366-70-1 | Procarbazine Hydrochloride

Packsize	Purity	Availability	Price	Discounted Price
250mg	98%	in stock	$30.00	$21.00
1g	98%	in stock	$59.00	$41.00
5g	98%	in stock	$193.00	$135.00

Description

• Catalog Number: AD37768
• Chemical Name: Procarbazine Hydrochloride
• CAS Number: 366-70-1
• Molecular Formula: C12H20ClN3O
• Molecular Weight: 257.7597
• MDL Number: MFCD00072082
• SMILES: CNNCc1ccc(cc1)C(=O)NC(C)C.Cl
• NSC Number: 77213

Computed Properties

• Complexity: 210
• Covalently-Bonded Unit Count: 2
• Heavy Atom Count: 17
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 4
• Rotatable Bond Count: 5

Literature

• Procarbazine and antidepressants: a retrospective review of the risk of serotonin toxicity.

  Psycho-oncology 20140101

• Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma.

  Leukemia & lymphoma 20121201

• Chemotherapy in low-grade gliomas.

  Current opinion in oncology 20121101

• Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center.

  Neuro-oncology 20121001

• Cryptococcal osteomyelitis and meningitis in a patient with non-hodgkin's lymphoma treated with PEP-C.

  BMJ case reports 20120907

• Procarbazine, carmustine, and vincristine (PBV) for chemotherapy pre-treated patients with recurrent glioblastoma: a single-institution analysis.

  Journal of neuro-oncology 20120901

• Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120901

• Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120720

• Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies.

  Journal of the National Cancer Institute 20120718

• Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120701

• Treatment of newly diagnosed advanced stage Hodgkin lymphoma.

  Blood reviews 20120701

• Escalated BEACOPP in advanced Hodgkin's lymphoma.

  Lancet (London, England) 20120512

• Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.

  Lancet (London, England) 20120512

• Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical Hodgkin lymphoma: high cure rates but increased risk of aseptic osteonecrosis.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120501

• Persistent genomic instability in peripheral blood lymphocytes from Hodgkin lymphoma survivors.

  Environmental and molecular mutagenesis 20120501

• Homonymous hemianopsia in a patient with Hodgkin's lymphoma in remission after BEACOPP chemotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120420

• Metronomic therapy for refractory/relapsed lymphoma: the PEP-C low-dose oral combination chemotherapy regimen.

  Hematology (Amsterdam, Netherlands) 20120401

• [Retrospective analysis of 157 patients with pediatric Hodgkin lymphoma in Japan: investigation by four pediatric cancer study groups].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20120401

• Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD14 trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120320

• Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.

  Leukemia & lymphoma 20120301

• Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma.

  British journal of haematology 20120301

• Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results.

  International journal of radiation oncology, biology, physics 20120201

• Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.

  International journal of radiation oncology, biology, physics 20120201

• A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas.

  Journal of neuro-oncology 20120201

• Clinical outcome in children and adolescents with Hodgkin lymphoma after treatment with chemotherapy alone - the results of the United Kingdom HD3 national cohort trial.

  European journal of cancer (Oxford, England : 1990) 20120101

• Prophylactic intrathecal chemotherapy in primary CNS lymphoma.

  Journal of neuro-oncology 20120101

• Role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone.

  Leukemia & lymphoma 20120101

• A 10-year experience with treatment of high and standard risk Hodgkin disease: six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved.

  American journal of hematology 20120101

• [Acquired ichthyosis and haematological malignancies: five cases].

  Annales de dermatologie et de venereologie 20120101

• [The optimal radiation volume after first-line chemotherapy in Hodgkin lymphoma].

  Voprosy onkologii 20120101

• [Role of response to first-line chemotherapy and of the primary lesion in Hodgkin lymphoma].

  Voprosy onkologii 20120101

• [Primary refractory and relapsed Hodgkin lymphoma with unfavorable prognosis].

  Voprosy onkologii 20120101

• [Relapse in Hodgkin lymphoma].

  Voprosy onkologii 20120101

• [Escalated BEACOPP as an alternative in high risk Hodgkin lymphoma].

  Przeglad lekarski 20120101

• Anaplastic oligodendroglial tumors harboring 1p/19q deletion can be successfully treated without radiotherapy.

  Anticancer research 20111201

• Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111110

• Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111110

• More is not necessarily better when treating Hodgkin's lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111110

• Chemotherapy: Hodgkin lymphoma--absence of evidence not evidence of absence!

  Nature reviews. Clinical oncology 20111004

• Ranimustine, ifosfamide, procarbazine, dexamethasone, and etoposide therapy for central nervous system recurrence of diffuse large B-cell lymphoma in patients with poor performance status: a pilot study.

  Leukemia & lymphoma 20111001

• Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy.

  Leukemia & lymphoma 20111001

• Chemotherapy for diffuse low-grade gliomas in adults.

  Revue neurologique 20111001

• Chemotherapy: Advanced Hodgkin lymphoma--balancing toxicity and cure.

  Nature reviews. Clinical oncology 20110906

• Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110901

• Chemotherapy only for localized Hodgkin lymphoma.

  Journal of internal medicine 20110901

• NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.

  Annals of neurology 20110901

• Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma.

  The Cochrane database of systematic reviews 20110810

• ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.

  The New England journal of medicine 20110721

• Hodgkin's lymphoma--the great teacher.

  The New England journal of medicine 20110721

• Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas.

  Pediatric blood & cancer 20110715

• Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009).

  Journal of the American Veterinary Medical Association 20110715

• Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition.

  International journal of radiation oncology, biology, physics 20110701

• Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.

  Cancer 20110701

• Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951.

  Journal of neuro-oncology 20110601

• International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors.

  Neuro-oncology 20110601

• Factors influencing the response to high dose methotrexate-based vincristine and procarbazine combination chemotherapy for primary central nervous system lymphoma.

  Journal of Korean medical science 20110401

• BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group.

  Blood 20110303

• Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110301

• Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses.

  British journal of haematology 20110301

• Adolescent hodgkin lymphoma: are treatment results more favorable with pediatric than with adult regimens?

  Journal of pediatric hematology/oncology 20110301

• [Fatal Bacillus cereus sepsis and rhabdomyolysis in a patient with Hodgkin's disease].

  Enfermedades infecciosas y microbiologia clinica 20110301

• Chemotherapy for thymic tumors: induction, consolidation, palliation.

  Thoracic surgery clinics 20110201

• Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS.

  Journal of experimental & clinical cancer research : CR 20110101

• Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies.

  Pediatric blood & cancer 20101201

• A predictive ligand-based Bayesian model for human drug-induced liver injury.

  Drug metabolism and disposition: the biological fate of chemicals 20101201

• Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogs.

  Veterinary and comparative oncology 20101201

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• A nonradiation-containing, intermediate-dose methotrexate regimen for elderly patients with primary central nervous system lymphoma.

  International journal of hematology 20101101

• Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101020

• Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update.

  Journal of neuro-oncology 20101001

• No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20101001

• Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas.

  Neuro-oncology 20101001

• Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease.

  Journal of pediatric hematology/oncology 20101001

• Hodgkin lymphoma and nephrotic syndrome in childhood.

  Indian journal of pediatrics 20101001

• Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.

  Anticancer research 20101001

• Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).

  Blood 20100923

• Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100920

• Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100810

• Testicular lymphoma, intraocular (vitreoretinal) lymphoma, and brain lymphoma: involvement of three immunoprivileged sites in one patient.

  American journal of hematology 20100801

• Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402.

  International journal of radiation oncology, biology, physics 20100701

• Hodgkin lymphoma presenting with hair graying.

  Journal of pediatric hematology/oncology 20100701

• Modified escalated BEACOPP as salvage chemotherapy in classic Hodgkin lymphoma.

  International journal of hematology 20100701

• The complex clinical picture of presumably allergic side effects to cytostatic drugs: symptoms, pathomechanism, reexposure, and desensitization.

  The Medical clinics of North America 20100701

• Eleventh biannual report of the Cochrane Haematological Malignancies Group: Focus on Hodgkin lymphoma.

  Journal of the National Cancer Institute 20100616

• Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma.

  Cancer 20100601

• Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100501

• Procarbazine-induced hepatotoxicity: case report and review of the literature.

  Pharmacotherapy 20100501

• Lipomatosis: an unusual side-effect of cytotoxic chemotherapy?

  Acta dermato-venereologica 20100501

• Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis.

  International journal of hematology 20100401

• Comparative study of two mechlorethamine, vincristine, procarbazine, and prednisone derived chemotherapeutic protocols for the management of pediatric Hodgkin lymphoma (HL): single-center 5-year experience.

  Leukemia & lymphoma 20100401

• Radiation-induced glioblastoma occurring 35 years after radiation therapy for medulloblastoma: case report.

  Brain tumor pathology 20100401

• The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.

  European journal of haematology 20100301

• IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100301

• Plasma levels of copper, manganese and selenium in an adult population in southern Spain: influence of age, obesity and lifestyle factors.

  The Science of the total environment 20100201

• Bevacizumab is active as a single agent against recurrent malignant gliomas.

  Anticancer research 20100201

• Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100101

• Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study.

  Neurosurgery 20100101

• Immune thrombocytopenic purpura at the diagnosis of Hodgkin disease.

  Acta clinica Belgica 20100101

• Non-Hodgkin's lymphoma: is India ready to incorporate recent advances in day to day practice?

  Journal of cancer research and therapeutics 20100101

• Impact of adjuvant chemotherapy for gliomatosis cerebri.

  BMC cancer 20100101

• Natural history and outcome of optic pathway gliomas in children.

  Pediatric blood & cancer 20091215

• Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma.

  Pediatric blood & cancer 20091215

• Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected].

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091210

• MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091210

• NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091210

• Long-term follow-up of survival in Hodgkin's lymphoma.

  The New England journal of medicine 20091210

• Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.

  Neuro-oncology 20091201

• Sunitinib paves the way for targeted therapies in neuroendocrine tumors.

  Targeted oncology 20091201

• Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.

  International journal of radiation oncology, biology, physics 20091201

• The early- and intermediate-term toxicity to primitive hematopoietic progenitor cells of three chemotherapy regimens for advanced hodgkin lymphoma.

  Clinical lymphoma & myeloma 20091201

• Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.

  Experimental hematology 20091101

• Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma.

  Leukemia & lymphoma 20091101

• Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?

  Leukemia & lymphoma 20091101

• First reported case of disease: peliosis hepatis as cardinal symptom of Hodgkin's lymphoma.

  The oncologist 20091101

• Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up.

  Leukemia & lymphoma 20091001

• Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090920

• Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090720

• Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.

  Annals of hematology 20090701

• FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090701

• Nail dystrophy due to dose-intensive chemotherapy.

  International journal of hematology 20090701

• [Clinicopathological diagnosis of gliomas by genotype analysis].

  Brain and nerve = Shinkei kenkyu no shinpo 20090701

• Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only.

  The Journal of clinical endocrinology and metabolism 20090601

• Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis.

  Blood 20090402

• Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma.

  Oncology reports 20090401

• Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs.

  Veterinary and comparative oncology 20090301

• Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents.

  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20090301

• ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090210

• High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090201

• [Composite lymphoma consisting of Hodgkin lymphoma and follicular lymphoma].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20090201

• Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.

  Anticancer research 20090201

• Successful treatment of hodgkin lymphoma in nijmegen breakage syndrome.

  Journal of pediatric hematology/oncology 20090101

• Granulomatous slack skin clinically and histologically masquerading as borderline leprosy in its early stages.

  European journal of dermatology : EJD 20090101

• [Concomitant pulmonary Langerhans cell histiocytosis and malignant lymphoma: report of two cases].

  Journal de radiologie 20090101

• Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs.

  Journal of veterinary internal medicine 20090101

• Retrospective analysis of treatment outcome in 315 patients with oligodendroglial brain tumors.

  BMC neurology 20090101

• Asparaginase and MOPP treatment of dogs with lymphoma.

  Journal of veterinary internal medicine 20090101

• Long-term survival of patients treated for Hodgkin's disease in 1971-1996 depending on the clinical stage of the disease, patient's fertility after therapy and cause of death analysis.

  Neoplasma 20090101

• [Multivariate analysis of risk of cardiac complications in Hodgkin's lymphoma].

  Voprosy onkologii 20090101

• Standard therapy of advanced Hodgkin lymphoma.

  Hematology. American Society of Hematology. Education Program 20090101

• Combination of rituximab and chemotherapy showing anti-tumor effect in gamma heavy chain disease expressing CD20.

  American journal of hematology 20081201

• Breast cancer after treatment of Hodgkin's lymphoma: general review.

  International journal of radiation oncology, biology, physics 20081201

• Vanishing bile duct syndrome and Hodgkin disease: a case series and review of the literature.

  Journal of pediatric hematology/oncology 20081201

• [Hodgkin's lymphoma in adolescents: where to treat it--in an adult or pediatric institution?].

  Orvosi hetilap 20081123

• Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma.

  Blood 20081115

• Prognostic factors in children with Hodgkin disease.

  Pediatric blood & cancer 20081101

• Different bone sesitivity to malformations induced by procarbazine in fetal rats.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20081101

• Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials.

  Annals of oncology : official journal of the European Society for Medical Oncology 20081001

• A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis.

  Journal of neuro-oncology 20080901

• Treatment of Hodgkin lymphoma: the past, present, and future.

  Nature clinical practice. Oncology 20080901

• Low-grade glioma: a challenge in therapeutic options: the role of radiotherapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080901

• [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20080801

• In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs.

  British journal of cancer 20080722

• Cerebellar dysfunction caused by procarbazine and consumption of excessive amount of bananas.

  Pediatric blood & cancer 20080601

• Indirect oxidation of the antitumor agent procarbazine by tyrosinase--possible application in designing anti-melanoma prodrugs.

  Bioorganic & medicinal chemistry letters 20080601

• Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.

  Cancer 20080515

• Single-molecule PCR analysis of germ line mutation induction by anticancer drugs in mice.

  Cancer research 20080515

• Results of treatment of 112 cases of primary CNS lymphoma.

  Japanese journal of clinical oncology 20080501

• When temozolomide alone fails: adding procarbazine in salvage therapy of glioma.

  The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20080501

• High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.

  Cancer 20080415

• Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients.

  Journal of neuro-oncology 20080401

• Low-dose metronomic, multidrug therapy with the PEP-C oral combination chemotherapy regimen for mantle cell lymphoma.

  Leukemia & lymphoma 20080301

• Hodgkin's Lymphoma in an elite endurance athlete.

  Medicine and science in sports and exercise 20080301

• Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

  The New England journal of medicine 20080214

• Proliferative index and CD15 expression in pediatric classical Hodgkin lymphoma.

  Pediatric blood & cancer 20080201

• Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin's lymphoma treated with the BAGCOPP regimen: a report by the German Hodgkin's Lymphoma Study Group.

  International journal of radiation oncology, biology, physics 20080101

• Treatment-related risk factors for premature menopause following Hodgkin lymphoma.

  Blood 20080101

• Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG).

  Blood 20080101

• Determination of terephthalic acid isopropylamide in urine with a liquid chromatography/mass spectrometry (LC/MS) method.

  Journal of clinical laboratory analysis 20080101

• [Features of clinical course of combination chemotherapy for liver involvement in Hodgkin's disease].

  Voprosy onkologii 20080101

• Procarbazine--a traditional drug in the treatment of malignant gliomas.

  Current medicinal chemistry 20080101

• [Efficacy of therapy of different variants of anaplastic large T-cell lymphomas].

  Terapevticheskii arkhiv 20080101

• Procarbazine and CCNU as initial treatment in gliomatosis cerebri.

  Oncology 20080101

• [Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents].

  Voprosy onkologii 20080101

• Serum cytokine in response to chemo-radiotherapy for Hodgkin's disease.

  Tumori 20080101

• Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071220

• Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.

  Human reproduction (Oxford, England) 20071201

• [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].

  Ai zheng = Aizheng = Chinese journal of cancer 20071201

• Prophylactic use of filgrastim with ABVD and BEACOPP chemotherapy regimens for Hodgkin lymphoma.

  Clinical lymphoma & myeloma 20071201

• A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgkin Study Group (GHSG).

  International journal of radiation oncology, biology, physics 20071115

• Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

  The New England journal of medicine 20071108

• Anaplastic oligodendroglioma and oligoastrocytoma.

  Neurologic clinics 20071101

• Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071020

• Long-term outcome of children and adolescents treated with the COPP-ABV hybrid protocol for Hodgkin's disease: balance of risks.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20071001

• Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood.

  The Journal of clinical endocrinology and metabolism 20071001

• Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report.

  British journal of haematology 20070901

• Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil.

  Pediatric blood & cancer 20070801

• [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].

  Deutsche medizinische Wochenschrift (1946) 20070801

• Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?

  Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20070801

• Is BEACOPP better than ABVD?

  Current hematologic malignancy reports 20070701

• Live birth after the transfer of human embryos developed from cryopreserved oocytes harvested before cancer treatment.

  Fertility and sterility 20070601

• Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.

  Oncology reports 20070601

• Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.

  Leukemia & lymphoma 20070601

• Central nervous system anaplastic large cell lymphoma in an adult: successful treatment with a combination of radiation and chemotherapy.

  Military medicine 20070601

• Long-term outcome in children with Hodgkin's lymphoma: the United Kingdom Children's Cancer Study Group HD82 trial.

  European journal of cancer (Oxford, England : 1990) 20070501

• Immuno-chemotherapy with a combination of rituximab, methotrexate, pirarubicin and procarbazine for patients with primary CNS lymphoma--a preliminary report.

  Leukemia & lymphoma 20070501

• [Our experiences in treating patients with Hodgkin disease in the last decade].

  Orvosi hetilap 20070415

• Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy.

  European journal of neurology 20070401

• Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).

  Hematology (Amsterdam, Netherlands) 20070401

• Astrocytic tumors in children: treatment results from a single institution.

  Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20070301

• Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy.

  Fertility and sterility 20070301

• [Hodgkin lymphoma in Chile: experience of the national adult cancer program].

  Revista medica de Chile 20070301

• Hodgkin lymphoma among patients infected with HIV in post-HAART era.

  Clinical lymphoma & myeloma 20070301

• Feasibility and response to 1-(4-amino-2-methyl-5-pyrimidynyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride chemotherapy with pre-treated procarbazine for elderly patients with newly diagnosed glioblastoma.

  Journal of neuro-oncology 20070201

• Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome.

  Blood 20070201

• Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070201

• Malignant fibrous histiocytoma following radiation therapy and chemotherapy for Hodgkin's lymphoma.

  International journal of clinical oncology 20070201

• Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.

  International journal of radiation oncology, biology, physics 20070101

• Procarbazine as adjunctive therapy for treatment of dogs with presumptive antemortem diagnosis of granulomatous meningoencephalomyelitis: 21 cases (1998-2004).

  Journal of veterinary internal medicine 20070101

• Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicity.

  Clinical pharmacokinetics 20070101

• Survival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decades.

  Anticancer research 20070101

• [Evolution in 18F-FDG-PET of a case of Hodgkin disease, nodular sclerosis variety, after treatment and autotrasplant].

  Revista espanola de medicina nuclear 20070101

• Hodgkin lymphoma in a child with sickle cell anemia.

  Pediatric hematology and oncology 20070101

• Risk, cure and complications in advanced hodgkin disease.

  Hematology. American Society of Hematology. Education Program 20070101

• Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061220

• Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.

  British journal of cancer 20061120

• High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol.

  European journal of cancer (Oxford, England : 1990) 20061101

• Information sources used by New South Wales cancer clinicians: a qualitative study.

  Internal medicine journal 20061101

• [Long-term outcome in patients with symptomatic low-grade oligodendrogliomatous tumors treated by cytotoxic agents].

  Revue neurologique 20061101

• Could BEACOPP be the new standard for the treatment of advanced Hodgkin's lymphoma (HL)?

  Cancer investigation 20061101

• Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas.

  British journal of cancer 20061009

• Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma--a 20-year follow-up.

  Annals of hematology 20061001

• Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061001

• A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.

  Cancer gene therapy 20060901

• Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.

  International journal of radiation oncology, biology, physics 20060901

• Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma.

  Leukemia & lymphoma 20060901

• [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].

  Ai zheng = Aizheng = Chinese journal of cancer 20060801

• Hodgkin's lymphoma in the elderly: the results of 10 years of follow-up.

  Leukemia & lymphoma 20060801

• Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma.

  Neuro-oncology 20060701

• Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060701

• Anaplastic oligodendroglial tumors: a tale of two trials.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060620

• Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060620

• Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060620

• Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

  Blood 20060615

• Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors.

  Neurology 20060613

• Hodgkin's lymphoma in adolescents.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060601

• POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group.

  Journal of pediatric hematology/oncology 20060601

• Gliomatosis cerebri treatment in 11 elderly patients.

  Journal of experimental & clinical cancer research : CR 20060601

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Will it be another 20 years before Hodgkin lymphoma patients benefit from BEACOPP therapy?

  Nature clinical practice. Oncology 20060501

• Fourth biannual report of the Cochrane Haematological Malignancies Group.

  Journal of the National Cancer Institute 20060419

• A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group.

  Journal of neuro-oncology 20060401

• High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.

  Neuro-oncology 20060401

• Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study.

  Haematologica 20060401

• [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].

  Ai zheng = Aizheng = Chinese journal of cancer 20060401

• Evaluation of acute and early cardiotoxicity in survivors of Hodgkin's disease treated with ABVD or BEACOPP regimens.

  Journal of chemotherapy (Florence, Italy) 20060401

• Something old, something new...

  Leukemia & lymphoma 20060401

• Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi.

  Leukemia & lymphoma 20060301

• Effect of a copper gradient on plant community structure.

  Environmental toxicology and chemistry 20060301

• [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20060301

• PCV chemotherapy for recurrent glioblastoma.

  Neurology 20060227

• Toxic epidermal necrolysis after PCV combination chemotherapy for relapsed B-cell lymphoma.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20060201

• Oligodendroglial tumor chemotherapy using 'decreased-dose-intensity' PCV: a Singapore experience.

  Neurology 20060124

• MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060115

• Hodgkin's disease in Indian children: outcome with chemotherapy alone.

  Pediatric blood & cancer 20060101

• A phase II study of VEPA/FEPP chemotherapy for aggressive lymphoma in elderly patients: Japan Clinical Oncology Group Study JCOG9203.

  International journal of hematology 20060101

• Could BEACOPP be the new standard for the treatment of advanced Hodgkin's lymphoma?

  Cancer investigation 20060101

• Hyperfractionated radiotherapy and multi-agent chemotherapy (procarbazine, ACNU and vincristine) for high-grade gliomas: a prospective study.

  Anticancer research 20060101

• [Limphomatous meningitis as recurrence site in Hodgkin's disease].

  Medicina 20060101

• [Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].

  Terapevticheskii arkhiv 20060101

• [Boron neutron capture therapy applied to undifferentiated thyroid carcinoma].

  Medicina 20060101

• ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220

• Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519).

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220

• Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.

  International journal of radiation oncology, biology, physics 20051201

• Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease.

  American journal of clinical oncology 20051201

• New treatment options have changed the survival of patients with follicular lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051120

• Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).

  International journal of radiation oncology, biology, physics 20051115

• Relapse of primary CNS lymphoma after more than 10 years in complete remission.

  Journal of neurology 20051101

• Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group.

  International journal of radiation oncology, biology, physics 20051101

• Procarbazine, lomustine, vincristine combination may be effective in adult medulloblastoma patients with systemic metastases.

  Journal of neuro-oncology 20051101

• Occurrence of multiple myeloma 13 years after Hodgkin's disease: chance or consequence?

  Annals of hematology 20051101

• BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease - results of the German Hodgkin Study Group.

  Leukemia & lymphoma 20051101

• Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051020

• A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma.

  International journal of radiation oncology, biology, physics 20050901

• Gemcitabine-induced radiation recall dermatitis in a patient with resistant Hodgkin lymphoma.

  American journal of hematology 20050901

• Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma.

  Journal of neuro-oncology 20050901

• Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials.

  Clinical lymphoma & myeloma 20050901

• The role of chemotherapy in the treatment of low-grade glioma. A review of the literature.

  Acta neurologica Belgica 20050901

• Oral combination chemotherapy in the treatment of AIDS-associated Hodgkin's disease.

  East African medical journal 20050901

• Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.

  Annals of hematology 20050701

• An unusual case of spontaneous remission of Hodgkin's disease after a single cycle of COPP-ABV chemotherapy followed by infectious complications.

  Yonsei medical journal 20050630

• ABVD, the Stanford V regimen, and BEACOPP for Hodgkin's lymphoma: what should an oncologist do?

  Clinical lymphoma 20050601

• Acquisition of a Ph chromosome with minor BCR/ABL fusion in treatment-related myelodysplastic syndrome with chromosome 7 abnormalities in a patient treated for Hodgkin disease.

  Cancer genetics and cytogenetics 20050501

• Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.

  European journal of cancer (Oxford, England : 1990) 20050501

• [Brief review of the neuro oncology for recent three decades in Japan].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050401

• [Resent advances in chemotherapy for malignant brain tumors].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050401

• Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050301

• Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.

  Cancer 20050215

• Fertility in males treated for Hodgkins disease with COPP/ABV hybrid.

  Pediatric blood & cancer 20050201

• Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa.

  Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20050201

• [Primary treatment of advanced Hodgkin's disease].

  Orvosi hetilap 20050130

• A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).

  Annals of oncology : official journal of the European Society for Medical Oncology 20050101

• Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma.

  British journal of haematology 20050101

• [A case of secondary non-Hodgkin's lymphoma of the colon after the treatment for Hodgkin's disease].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20050101

• Semi-quantification of methionine uptake and flair signal for the evaluation of chemotherapy in low-grade oligodendroglioma.

  Journal of neuro-oncology 20050101

• Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma.

  Chang Gung medical journal 20050101

• Benefit of temozolomide compared to procarbazine in treatment of glioblastoma multiforme at first relapse: effect on neurological functioning, performance status, and health related quality of life.

  Cancer investigation 20050101

• Intracranial involvement in Hodgkin's disease.

  Pediatric hematology and oncology 20050101

• Efficacy and feasibility of procarbazine, ranimustine and vincristine chemotherapy, and the role of surgical resection in anaplastic oligodendroglioma.

  Anticancer research 20050101

• Evolving approaches to primary treatment of Hodgkin lymphoma.

  Hematology. American Society of Hematology. Education Program 20050101

• Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapy.

  Hematology. American Society of Hematology. Education Program 20050101

• Treatment of low-grade oligodendroglial tumors without radiotherapy.

  Neurology 20041228

• [Treatment of primary mediastinal large B-cell lymphomas].

  Orvosi hetilap 20041212

• Significance of splenomegaly in childhood Hodgkin disease.

  Journal of pediatric hematology/oncology 20041201

• Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041115

• Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study.

  Cancer 20041101

• [The molecular genetics of oligodendroglioma].

  Zhonghua bing li xue za zhi = Chinese journal of pathology 20041001

• Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas.

  Neurology 20040914

• Do folic acid and thiocyanate have a preventive effect on exogenously induced disturbances of embryonic cranial development?

  Clinical oral investigations 20040901

• [Action of Natulan in 94 solid tumours. 1966].

  European journal of cancer (Oxford, England : 1990) 20040901

• Procarbazine in haematology: an old drug with a new life?

  European journal of cancer (Oxford, England : 1990) 20040901

• The enhancement of the after effect of ionizing radiation by a cytotoxic methylhydrazine derivative. 1966.

  European journal of cancer (Oxford, England : 1990) 20040901

• The emerging role of reactive oxygen species in cancer therapy.

  European journal of cancer (Oxford, England : 1990) 20040901

• Progress in the prognosis of adult Hodgkin's lymphoma in the past 35 years through clinical trials in Argentina: a GATLA experience.

  Clinical lymphoma 20040901

• Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.

  Neurology 20040810

• Gliomatosis cerebri: better definition, better treatment.

  Neurology 20040727

• Initial chemotherapy in gliomatosis cerebri.

  Neurology 20040727

• Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.

  Pediatric blood & cancer 20040701

• Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.

  International journal of radiation oncology, biology, physics 20040701

• Teaching cases from the Royal Marsden and St Mary's Hospitals, case 26: refractory microcytic anaemia.

  Leukemia & lymphoma 20040701

• Severe pulmonary toxicity in patients with advanced-stage Hodgkin's disease treated with a modified bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, and gemcitabine (BEACOPP) regimen is probably related to the combination of gemcitabine and bleomycin: a report of the German Hodgkin's Lymphoma Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040615

• ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysis.

  British journal of haematology 20040601

• Decreased serum inhibin B/FSH ratio as a marker of Sertoli cell function in male survivors after chemotherapy in childhood and adolescence.

  Journal of pediatric endocrinology & metabolism : JPEM 20040601

• Long-term outcome of oligodendrogliomas.

  Neurology 20040525

• [Neoadjuvant chemotherapy for symptomatic non operable grade II fibrillary astrocytoma in adults].

  Revue neurologique 20040501

• Randomized controlled trial on malignant brain tumors--activities of the Japan Clinical Oncology Group-Brain Tumor Study Group.

  Neurologia medico-chirurgica 20040401

• Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.

  International journal of radiation oncology, biology, physics 20040315

• Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.

  International journal of radiation oncology, biology, physics 20040315

• Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats.

  Biochemical and biophysical research communications 20040305

• Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease.

  Pediatric blood & cancer 20040301

• Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.

  Annals of hematology 20040301

• Pediatric Hodgkin's disease.

  The Journal of the Kentucky Medical Association 20040301

• Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.

  Cancer 20040215

• Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.

  Neurology 20040210

• Monitoring individual response to brain-tumour chemotherapy: proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy.

  Neuroradiology 20040201

• Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040201

• Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040201

• Limited field radiotherapy for early stage, infra-diaphragmatic Hodgkin's lymphoma.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20040201

• Determination of procarbazine in human plasma by liquid chromatography with electrospray ionization mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040125

• VEPEMB in elderly Hodgkin's lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040101

• What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?

  Current hematology reports 20040101

• Secondary axillary node carcinoma following treatment of Hodgkin's disease.

  The breast journal 20040101

• Phase II study of cisplatin and 5-fluorouracil (PF) and mitomycin C, vincristine, cisplatin and 5-fluorouracil (MVPF) in patients with metastatic large bowel cancer: an Eastern Cooperative Oncology Group study (EST 1285).

  Oncology 20040101

• Reduction of procarbazine-induced cleft palates by prenatal folic acid supplementation in rats.

  Pathology, research and practice 20040101

• [Treating Hodgkin's disease: for whom the more means better?].

  Magyar onkologia 20040101

• [Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications].

  Przeglad lekarski 20040101

• [Primary lymphoma of the thyroid: a case report].

  Dakar medical 20040101

• Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.

  Cancer 20031215

• Oligodendroglioma.

  Current treatment options in oncology 20031201

• Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.

  International journal of radiation oncology, biology, physics 20031201

• Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.

  Bone marrow transplantation 20031201

• The role of PCV chemotherapy in the treatment of central neurocytoma: illustration of a case and review of the literature.

  Surgical neurology 20031201

• Cardiac lymphoma successfully treated with high dose chemotherapy followed by autologous haematopoietic stem cell transplantation.

  Haematologica 20031201

• The treatment of adults with medulloblastoma: a prospective study.

  International journal of radiation oncology, biology, physics 20031101

• Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis.

  Surgical neurology 20031101

• High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma.

  Journal of neuro-oncology 20031101

• Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031001

• Treatment of intermediate and advanced stage Hodgkin's disease with modified baseline BEACOPP regimen: a Hellenic Co-operative Oncology Group Study.

  European journal of haematology 20031001

• BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection.

  Annals of oncology : official journal of the European Society for Medical Oncology 20031001

• [Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20031001

• Sex-related differences in procarbazine-induced cleft palate and microgenia and the anti-teratogenic effect of prenatal folic acid supplementation in rats.

  Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft 20031001

• [Hematologic tumors].

  Gan to kagaku ryoho. Cancer & chemotherapy 20031001

• Chemotherapy for Hodgkin's disease.

  The New England journal of medicine 20030918

• Radiotherapy for advanced Hodgkin's disease.

  The New England journal of medicine 20030918

• Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri.

  Neurology 20030812

• Molecular mechanisms of DNA damage induced by procarbazine in the presence of Cu(II).

  Mutation research 20030805

• Phase I study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas.

  British journal of cancer 20030721

• Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030715

• Radiation therapy in the treatment of Hodgkin's disease--do you see what I see?

  Journal of the National Cancer Institute 20030702

• Analysis of treatment results in advanced Hodgkin's disease: the case for adjuvant radiotherapy.

  International journal of radiation oncology, biology, physics 20030701

• Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.

  International journal of radiation oncology, biology, physics 20030701

• Tolerance of nitrosurea-based multiagent chemotherapy regime for low-grade pediatric gliomas.

  Journal of neuro-oncology 20030701

• Revascularization for acute coronary occlusion in a young woman following radiation.

  Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20030701

• High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030615

• Hodgkin's disease--clinical trials and travails.

  The New England journal of medicine 20030612

• Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.

  The New England journal of medicine 20030612

• Involved-field radiotherapy for advanced Hodgkin's lymphoma.

  The New England journal of medicine 20030612

• Conformal irradiation for pure and mixed oligodendroglioma: the experience of Centre Leon Berard Lyon.

  International journal of radiation oncology, biology, physics 20030501

• 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030501

• Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030401

• [Hodgkin's disease manifesting as paraneoplastic limbic encephalitis].

  La Revue de medecine interne 20030401

• Prospective trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20030401

• A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival.

  Blood 20030315

• Interobserver variability in the radiological assessment of response to chemotherapy in glioma.

  Neurology 20030311

• Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

  Blood 20030301

• Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.

  Pediatric hematology and oncology 20030301

• Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.

  Cancer 20030301

• Concurrent mediastinal B cell lymphoma and chronic myeloid leukemia with an unusually favorable response to chemotherapy.

  Leukemia & lymphoma 20030301

• Advanced Hodgkin's disease: ABVD is better, yet is not good enough!

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030215

• Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030215

• A prospective study on glioblastoma in the elderly.

  Cancer 20030201

• [Relapse of Hodgkin disease after 17 years of complete remission. A case report].

  Revista medica de Chile 20030201

• Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030115

• Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri.

  Neurology 20030114

• Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.

  Medical and pediatric oncology 20030101

• Identification of novel enzyme-prodrug combinations for use in cytochrome P450-based gene therapy for cancer.

  Archives of biochemistry and biophysics 20030101

• [Erythema nodosum association with malignant lymphoma].

  Medicina (Kaunas, Lithuania) 20030101

• Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook.

  Klinische Padiatrie 20030101

• Current chemotherapy for glioblastoma.

  Cancer journal (Sudbury, Mass.) 20030101

• Chemotherapy for progressive low-grade gliomas in children older than ten years: the Dana-Farber experience.

  Pediatric hematology and oncology 20030101

• [Use of modern technologies in the diagnosis and combined treatment of brain stem tumors].

  Vestnik Rossiiskoi akademii meditsinskikh nauk 20030101

• Medication sheets for patients. Oral chemotherapy.

  Clinical journal of oncology nursing 20030101

• Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.

  Blood 20021215

• An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.

  Cancer 20021215

• Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021215

• ChlVPP chemotherapy in children with stage IV Hodgkin's disease: results of the UKCCSG HD 8201 and HD 9201 studies.

  British journal of haematology 20021201

• Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021201

• Postpneumonectomy-like syndrome after chemoradiation therapy for lymphoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021201

• Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin's disease (Croatian experience).

  Annals of oncology : official journal of the European Society for Medical Oncology 20021001

• Hodgkin s disease with nephrotic syndrome as a complication of ulcerative colitis: case report.

  Croatian medical journal 20021001

• Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020915

• Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease.

  Current oncology reports 20020901

• Complete response of a recurrent, multicentric malignant glioma in a patient treated with phenylbutyrate.

  Journal of neuro-oncology 20020901

• Non-Hodgkin's lymphomas.

  Clinical obstetrics and gynecology 20020901

• New treatments for Hodgkin's disease.

  Current treatment options in oncology 20020801

• Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendroglioma.

  Journal of neurology 20020801

• VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020715

• ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020701

• Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.

  British journal of haematology 20020701

• Acute tumor lysis syndrome in Hodgkin disease.

  Medical and pediatric oncology 20020701

• A multidrug combination designed for reversing resistance to BCNU in glioblastoma multiforme.

  Neurology 20020625

• Long-term follow-up in managing anaplastic astrocytoma by multimodality approach with surgery followed by postoperative radiotherapy and PCV-chemotherapy: phase II trial.

  American journal of clinical oncology 20020601

• Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.

  International journal of radiation oncology, biology, physics 20020501

• [Chemo-radiotherapy for malignant brain tumors].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020501

• Concurrent modified PCV chemotherapy and radiotherapy in newly diagnosed grade IV astrocytoma.

  Journal of neuro-oncology 20020501

• Pulmonary toxicity secondary to procarbazine.

  American journal of clinical oncology 20020401

• [A case of Hodgkin's disease of mesenteric origin].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20020401

• Superior efficacy of MMCP regimen compared with VMCP and MMPP regimens in the treatment of multiple myeloma.

  Internal medicine (Tokyo, Japan) 20020401

• European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.

  Cancer 20020315

• Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020215

• Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study.

  Melanoma research 20020201

• [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].

  Ideggyogyaszati szemle 20020120

• Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020115

• Subdiaphragmatic Hodgkin's disease: the University of Florida experience.

  International journal of radiation oncology, biology, physics 20020101

• Paucity of hematological neoplasia after treatment of Hodgkin disease: observation after long-term follow-up at Cancer Institute, Chennai, south India.

  Pediatric hematology and oncology 20020101

• Treatment of elderly Hodgkin's lymphoma patients. The experience of the Italian Lymphoma Intergroup.

  Tumori 20020101

• Feasibility of upfront dose-intensive chemotherapy in children with advanced-stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group Study CCG-59704.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020101

• Current clinical trials for the treatment of advanced-stage Hodgkin's disease: BEACOPP.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020101

• Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure: a phase II study.

  Oncology 20020101

• [Cured from Hodgkin's disease].

  Bulletin du cancer 20020101

• MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989-2000).

  Journal of veterinary internal medicine 20020101

• Radiotherapy alone for lymphocyte-predominant Hodgkin's disease.

  Cancer journal (Sudbury, Mass.) 20020101

• Granulocytic sarcoma occurring in the maxillary gingiva demonstrated by magnetic resonance imaging.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20011201

• Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero.

  Clinical lymphoma 20011201

• Adults with newly diagnosed high-grade gliomas.

  Current treatment options in oncology 20011201

• Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.

  Blood 20011115

• Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.

  Annals of hematology 20011101

• A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation.

  Bone marrow transplantation 20011101

• Medical Research Council adjuvant trial in high-grade gliomas.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011001

• Medroxyprogesterone acetate alone or synergistic with chemotherapy suppresses colony formation and DNA synthesis in C6 glioma in vitro.

  International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20011001

• Chemotherapy plus interferon-alpha2b versus chemotherapy in the treatment of follicular lymphoma.

  Journal of hematotherapy & stem cell research 20011001

• PCV chemotherapy for oligodendroglioma: response analyzed on T2 weighted-MRI.

  Journal of neuro-oncology 20011001

• ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010901

• Advanced Hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy: a study of 82 patients from the Groupes d'Etudes des Lymphomes de l'Adulte H89 trial.

  Cancer 20010801

• Chemotherapy for the treatment of oligodendroglial tumors.

  Seminars in oncology 20010801

• Transformation of Hodgkin's disease to high-grade B-cell lymphoma: remission after Rituximab monotherapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010801

• Is it possible to prevent cleft palate by prenatal administration of folic acid? An experimental study.

  The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association 20010701

• Neurofibromatosis type 1-associated unusual pleomorphic astrocytoma displaying continual malignant progression.

  Pathology international 20010701

• The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease.

  Leukemia & lymphoma 20010701

• Hodgkin's disease complicated by the nephrotic syndrome in a man with Kugelberg-Welander disease.

  Leukemia & lymphoma 20010701

• PCV chemotherapy for recurrent glioblastoma multiforme.

  Neurology 20010626

• Anti-genotoxicity of trans-anethole and eugenol in mice.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20010501

• Primary pelvic non-Hodgkin's lymphoma.

  Obstetrics and gynecology 20010501

• ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial.

  British journal of cancer 20010501

• Chemotherapy of low-grade gliomas.

  Seminars in radiation oncology 20010401

• Multidisciplinary management of adult anaplastic oligodendrogliomas and anaplastic mixed oligo-astrocytomas.

  Seminars in radiation oncology 20010401

• The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hospital.

  International journal of radiation oncology, biology, physics 20010401

• [The chemotherapeutic treatment of advanced Hodgkin's disease].

  Harefuah 20010401

• Fotemustine combined with procarbazine in recurrent malignant gliomas: a phase I study with evaluation of lymphocyte 06-alkylguanine-DNA alkyltransferase activity.

  Journal of neuro-oncology 20010401

• Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010315

• Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010301

• Early occurrence of a secondary thyroid carcinoma in a child treated for Hodgkin disease.

  Medical and pediatric oncology 20010301

• Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma: evaluation of the role of G-CSF; quality-of-life analysis and long-term follow-up.

  American journal of hematology 20010301

• Efficacy of adjuvant therapy with procarbazine, MCNU, and vincristine for oligodendroglial tumors.

  Neurologia medico-chirurgica 20010301

• [Can 67Ga citrate predict the efficacy of chemotherapy early in Hodgkin's lymphoma?].

  Revista espanola de medicina nuclear 20010201

• Cyclophosphamide-based, seven-drug hybrid and low-dose involved field radiation for the treatment of childhood and adolescent Hodgkin disease.

  Journal of pediatric hematology/oncology 20010201

• Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010115

• PCV chemotherapy for recurrent glioblastoma multiforme.

  Neurology 20010109

• Radiotherapy of esthesioneuroblastoma.

  International journal of radiation oncology, biology, physics 20010101

• A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma.

  European journal of haematology 20010101

• Persistent paraneoplastic neurologic syndrome after successful therapy of Hodgkin's disease.

  European journal of haematology 20010101

• Hodgkin's disease: clinical presentation and treatment.

  Cancer treatment and research 20010101

• Gingival overgrowth as the initial paraneoplastic manifestation of Hodgkin's lymphoma in a child. A case report.

  Journal of periodontology 20010101

• Treatment of advanced stage Hodgkin's disease.

  Oncology 20010101

• Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.

  Oncology 20010101

• Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481).

  Leukemia & lymphoma 20010101

• [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].

  La Clinica terapeutica 20010101

• The effects of GnRH analogues and antiandrogenes in preventing the gonadotoxic effects of COPP chemotherapy.

  International urology and nephrology 20010101

• Peroneal mononeuropathy in pediatric Hodgkin's disease.

  Leukemia & lymphoma 20001201

• Treatment for primary CNS lymphoma: the next step.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20000901

• Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.

  Neuro-oncology 20000401

• Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The Lymphoma Study Group of the Japan Clinical Oncology Group.

  Japanese journal of clinical oncology 20000301

• Carboxypeptidase G2 rescue in a 79 year-old patient with cranial lymphoma after high-dose methotrexate induced acute renal failure.

  Leukemia & lymphoma 19991101

• Aortic dissection in a patient receiving chemotherapy for Hodgkin's disease--a case report.

  Angiology 19971201

• [Doxorubicin-induced myocardial damage in elderly patients with hematologic malignancies].

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 19970101

• In vivo effects of COPP protocol on onco- and suppressor gene expression in a 'follow up study'.

  In vivo (Athens, Greece) 19970101

• Therapy-related leukemia with a novel 21q22 rearrangement.

  Cancer genetics and cytogenetics 19960801

• Genetic instability in patients with Hodgkin's disease undergoing chemotherapy.

  The Journal of clinical investigation 19951201

• Further studies on the ex-vivo effects of procarbazine and monomethylhydrazine on rat semicarbazide-sensitive amine oxidase and monoamine oxidase activities.

  The Journal of pharmacy and pharmacology 19951001

• Molecular analysis of four lactate dehydrogenase-A mutants in the mouse.

  Mammalian genome : official journal of the International Mammalian Genome Society 19941201

• Visual hallucinations following treatment with vincristine.

  Clinical and laboratory haematology 19941201

• Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19941001

• Aplastic anemia induced by cyclohexylchloroethylnitrousurea.

  Anti-cancer drugs 19940201

• Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement.

  Annals of oncology : official journal of the European Society for Medical Oncology 19940101

• Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults.

  Leukemia & lymphoma 19931001

• Cardiorespiratory decompensation following methylprednisolone administration.

  Pediatric hematology and oncology 19930101

• Alteration of mRNA transcript levels of rat testicular cells following procarbazine administration.

  Journal of andrology 19930101

• Combined intra-arterial and systemic chemotherapy for recurrent malignant brain tumors.

  Neurosurgery 19920201

• [Recurrent paralysis induced by vincristine during the treatment of Hodgkin's disease].

  Presse medicale (Paris, France : 1983) 19891125

• [Secondary leukemia (AML) with TcR beta rearrangement].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 19890801

• Dominant cataract and recessive specific-locus mutations detected in offspring of procarbazine-treated male mice.

  Mutation research 19880401

• Procarbazine is a potent mutagen at the heterozygous thymidine kinase (tk +/-) locus of mouse lymphoma assay.

  Mutagenesis 19880301

• Renal impairment following the combined use of high-dose methotrexate and procarbazine.

  Cancer chemotherapy and pharmacology 19880101

• Reversible mechlorethamine-associated hearing loss in a patient with Hodgkin's disease.

  Cancer 19860315

• MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19850901

• BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study.

  Annals of internal medicine 19841001

• Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.

  Annals of internal medicine 19841001

• Dominant lethal mutations induced in mouse spermatogonia by antineoplastic drugs.

  Mutation research 19840801

• Immediate and delayed neurotoxicity after mechlorethamine preparation for bone marrow transplantation.

  Annals of internal medicine 19820801

• Manic psychosis associated with procarbazine.

  British medical journal (Clinical research ed.) 19820109

• Mouse spermatogonia exposed to a high, multiply fractionated dose of a cancer chemotherapeutic drug: mutation analysis by electrophoresis.

  Mutation research 19810401

• Action of N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride (procarbazine hydrochloride) in the germ tissue of mice: dominant lethal effects.

  Archives of toxicology 19790223

• Optic neuroretinitis in association with BCNU and procarbazine therapy.

  Medical and pediatric oncology 19780101

• Central nervous system disturbances after combined administration of procarbazine and mechlorethamine.

  Cancer treatment reports 19771201

• [Increased hematological toxicity of antineoplastic drugs with simultaneous androgenotherapy (author's transl)].

  La Nouvelle presse medicale 19770917

• Single-agent chemotherapy of brain tumors. A five-year review.

  Archives of neurology 19761101

• Immunosuppressive and cytotoxic chemotherapy: long-term complications.

  Annals of internal medicine 19750101

• Combination chemotherapy of lymphomas other than Hodgkin's disease.

  Annals of internal medicine 19741101

• Combination chemotherapy of Hodgkin's disease in private practice.

  JAMA 19720717

• [Induction of malignomas in rats after transplacental exposure to N-isopropyl-alpha-2-(methyl-hydrazino)-p-toluamide-HCl].

  Arzneimittel-Forschung 19720501

• The immunosuppressive activity of procarbazine hydrochloride in canine renal allografts by donor pretreatment.

  Journal of surgical oncology 19720101